Common genetic variation in KATNAL1 non-coding regions is involved in the susceptibility to severe phenotypes of male infertility.

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Cervan-Martin, Miriam
- Bossini-Castillo, Lara
- Guzman-Jimenez, Andrea
- Santos-Ribeiro, Samuel
- Group, Ivirma
- Group, Lisbon Clinical
- Castilla, Jose A
- Gonzalvo, M Carmen
- Clavero, Ana
- Maldonado, Vicente
- Vicente, F Javier
- Burgos, Miguel
- Jimenez, Rafael
- Gonzalez-Munoz, Sara
- Sanchez-Curbelo, Josvany
- Lopez-Rodrigo, Olga
- Pereira-Caetano, Iris
- Marques, Patricia I
- Carvalho, Filipa
- Barros, Alberto
- Bassas, Lluis
- Seixas, Susana
- Goncalves, Joao
- Larriba, Sara
- Lopes, Alexandra M
- Palomino-Morales, Rogelio J
- Carmona, F David
Grupos
Abstract
Background Previous studies in animal models evidenced that genetic mutations of KATNAL1, resulting in dysfunction of its encoded protein, lead to male infertility through disruption of microtubule remodelling and premature germ cell exfoliation. Subsequent studies in humans also suggested a possible role of KATNAL1 single-nucleotide polymorphisms in the development of male infertility as a consequence of severe spermatogenic failure. Objectives The main objective of the present study is to evaluate the effect of the common genetic variation of KATNAL1 in a large and phenotypically well-characterised cohort of infertile men because of severe spermatogenic failure. Materials and methods A total of 715 infertile men because of severe spermatogenic failure, including 210 severe oligospermia and 505 non-obstructive azoospermia patients, as well as 1058 unaffected controls were genotyped for three KATNAL1 single-nucleotide polymorphism taggers (rs2077011, rs7338931 and rs2149971). Case-control association analyses by logistic regression assuming different models and in silico functional characterisation of risk variants were conducted. Results Genetic associations were observed between the three analysed taggers and different severe spermatogenic failure groups. However, in all cases, the haplotype model (rs2077011*C | rs7338931*T | rs2149971*A) better explained the observed associations than the three risk alleles independently. This haplotype was associated with non-obstructive azoospermia (adjusted p = 4.96E-02, odds ratio = 2.97), Sertoli-cell only syndrome (adjusted p = 2.83E-02, odds ratio = 5.16) and testicular sperm extraction unsuccessful outcomes (adjusted p = 8.99E-04, odds ratio = 6.13). The in silico analyses indicated that the effect on severe spermatogenic failure predisposition could be because of an alteration of the KATNAL1 splicing pattern. Conclusions Specific allelic combinations of KATNAL1 genetic polymorphisms may confer a risk of developing severe male infertility phenotypes by favouring the overrepresentation of a short non-functional transcript isoform in the testis.
© 2022 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.
Datos de la publicación
- ISSN/ISSNe:
- 2047-2919, 2047-2927
- Tipo:
- Article
- Páginas:
- 1339-1350
- DOI:
- 10.1111/andr.13221
- Factor de Impacto:
- 0,772 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
ANDROLOGY John Wiley and Sons Inc.
Documentos
- No hay documentos
Filiaciones
Keywords
- KATNAL1; male infertility; SNP; spermatogenesis; splicing
Proyectos asociados
Evalución del tratamiento clínico en varones con oligospermia severa, fallos de ICSI y elevada fragmentación de ADN mediante el uso de espermatozoides testiculares.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
PI18/00325 . INSTITUTO DE SALUD CARLOS III . 2019
Contrato PFIS: Predoctorales de formación en investigación en salud.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
FI19/00051 . INSTITUTO DE SALUD CARLOS III . 2020
ENSAYO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO PARA INVESTIGAR LA EFICACIA Y SEGURIDAD DE DOS CONCENTRACIONES DE PKB171 FRENTE A PLACEBO EN PAREJAS CON ASTENOZOOSPERMIA QUE DESEAN CONCEBIR.
Investigador Principal: JOSÉ MARÍA RUBIO RUBIO
PKB171-02 . 2017
GENETIC EFFECTS IN SPERM DNA AFTER TESTICULAR CANCER TREATMENT.
Investigador Principal: SATURNINO LUJÁN MARCO
1901-BCN-011-MQ . 2020
Influencia del virus del papiloma humano (VPH) en semen sobre los resultados reproductivos y lavado de semen con heparinasa como opción terapéutica en la infección.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
PI21/00322 . INSTITUTO DE SALUD CARLOS III . 2022
Resonancia Magnética y Biomarcadores de imagen para el mapeo, localización de focos de espermatogénesis y guiado de las biopsias testiculares en pacientes con azoospermia no obstructiva.
Investigador Principal: JOSÉ REMOHÍ GIMÉNEZ
PI21/00424 . INSTITUTO DE SALUD CARLOS III . 2022
Resonancia Magnética y biomarcadores de imagen para el mapeo, localización de focos de espermatogénesis y guiado de las biopsias testiculares en pacientes con azoospermia no obstructiva.
Investigador Principal: SATURNINO LUJÁN MARCO
2003-FIVI-021-NG . 2021
Análisis del biomarcador epigenético en el semen involucrado en el riesgo de autismo en la descendencia.
Investigador Principal: ANA VICTORIA MARCO HERNÁNDEZ
2103-FIVI-022-NG . 2021
Cita
Cervan M,Bossini L,Guzman A,Rivera R,Garrido N,Lujan S,Romeu G,Santos S,Group I,Group LC,Castilla JA,Gonzalvo MC,Clavero A,Maldonado V,Vicente FJ,Burgos M,Jimenez R,Gonzalez S,Sanchez J,Lopez O,Pereira I,Marques PI,Carvalho F,Barros A,Bassas L,Seixas S,Goncalves J,Larriba S,Lopes AM,Palomino RJ,Carmona FD. Common genetic variation in KATNAL1 non-coding regions is involved in the susceptibility to severe phenotypes of male infertility. Andrology. 2022. 10. (7):p. 1339-1350. IF:4,500. (1).